All individual trials at Insulet Corporation

An AllTrials project

All individual trials at Insulet Corporation

6 out of 9

66.7%

$65,711,920

$0

Status	Sponsor	Trial ID	Title	Completion date	Days overdue
overdue	Insulet Corporation	NCT02897557	A Prospective Early Feasibility Study to Assess the Performance of the Insulet Artificial Pancreas (AP) System Using the OmniPod® Insulin Management System and the Dexcom G4® Share™ AP System [pACT]	2017-02-28	2819
reported-late	Insulet Corporation	NCT04176731	Prepivotal Evaluation of the Safety and Effectiveness of the Omnipod Horizon™ Automated Glucose Control System in Patients With Type 1 Diabetes	2020-01-31	859
reported-late	Insulet Corporation	NCT04196140	Evaluating the Safety and Effectiveness of the Omnipod Horizon™ Automated Glucose Control System in Patients With Type 1 Diabetes	2020-07-10	843
reported-late	Insulet Corporation	NCT04320069	Evaluating the Safety and Effectiveness of the Omnipod Horizon™ CGM-informed Bolus Calculator in Patients With Type 1 Diabetes	2020-09-29	618
reported-late	Insulet Corporation	NCT04476472	Evaluating the Safety and Effectiveness of the Omnipod Horizon™ Automated Glucose Control System in Children With Type 1 Diabetes Aged 2.0-5.9 Years: Preschool Cohort	2022-01-17	301
reported-late	Insulet Corporation	NCT05409131	Efficacy and Safety of the Omnipod 5 System Compared to Pump Therapy in the Treatment of Type 1 Diabetes: a Randomized, Parallel-group Clinical Trial	2023-09-14	59
overdue	Insulet Corporation	NCT06181721	Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes	2024-01-31	290
reported-late	Insulet Corporation	NCT05815342	Safety and Efficacy of the Omnipod 5 Automated Insulin Delivery System in Adults With Type 2 Diabetes	2024-03-01	54
overdue	Insulet Corporation	NCT05923827	Randomized Controlled Trial to Demonstrate the Efficacy of the Omnipod® 5 System When Compared to Multiple Daily Injections for Treatment of Type 1 Diabetes (RADIANT)	2024-08-02	107
ongoing	Insulet Corporation	NCT06547918	Safety and Effectiveness of the Omnipod® 5 SmartAdjust 2.0 System in Individuals With Type 1 and Type 2 Diabetes	2025-09-30
ongoing	Insulet Corporation	NCT06865989	Safety and Efficacy of the Omnipod® SmartAdjust 2.0 System Compared to the Omnipod® 5 System in Individuals With Type 1 or Type 2 Diabetes	2025-11-30
ongoing	Insulet Corporation	NCT07039981	Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Adults With Type 2 Diabetes	2025-12-08
ongoing	Insulet Corporation	NCT07070830	Feasibility of Simplified Onboarding in Adults With Type 2 Diabetes Using Automated Insulin Delivery	2026-01-31

Download this data